Extrafacial necrobiotic xanthogranuloma and a disseminated marginal zone B lymphoma: a unique tissue collision

International Journal of DermatologyEarly View Correspondence Extrafacial necrobiotic xanthogranuloma and a disseminated marginal zone B lymphoma: a unique tissue collision Salomé Fourmond MD, Salomé Fourmond MD Dermatology Department, CHU de Bordeaux, Bordeaux, FranceSearch for more papers by this authorAnne Pham-Ledard MD, PhD, Anne Pham-Ledard MD, PhD Dermatology Department, CHU de Bordeaux, Bordeaux, France Translational Research on Oncodermatology and Rare Skin Diseases, INSERM U1312, Bordeaux Institute of Oncology, Bordeaux University, Bordeaux, FranceSearch for more papers by this authorBeatrice Vergier MD, PhD, Beatrice Vergier MD, PhD Translational Research on Oncodermatology and Rare Skin Diseases, INSERM U1312, Bordeaux Institute of Oncology, Bordeaux University, Bordeaux, France Pathology Department, CHU Bordeaux, Bordeaux, FranceSearch for more papers by this authorItzia Peyrot MD, Itzia Peyrot MD Dermatology Department, CHU de Bordeaux, Bordeaux, FranceSearch for more papers by this authorMarie Beylot-Barry MD, PhD, Marie Beylot-Barry MD, PhD orcid.org/0000-0001-6150-1229 Dermatology Department, CHU de Bordeaux, Bordeaux, France Translational Research on Oncodermatology and Rare Skin Diseases, INSERM U1312, Bordeaux Institute of Oncology, Bordeaux University, Bordeaux, FranceSearch for more papers by this authorOcéane Ducharme MD, Corresponding Author Océane Ducharme MD [email protected] Dermatology Department, CHU de Bordeaux, Bordeaux, France Translational Research on Oncodermatology and Rare Skin Diseases, INSERM U1312, Bordeaux Institute of Oncology, Bordeaux University, Bordeaux, FranceSearch for more papers by this author Salomé Fourmond MD, Salomé Fourmond MD Dermatology Department, CHU de Bordeaux, Bordeaux, FranceSearch for more papers by this authorAnne Pham-Ledard MD, PhD, Anne Pham-Ledard MD, PhD Dermatology Department, CHU de Bordeaux, Bordeaux, France Translational Research on Oncodermatology and Rare Skin Diseases, INSERM U1312, Bordeaux Institute of Oncology, Bordeaux University, Bordeaux, FranceSearch for more papers by this authorBeatrice Vergier MD, PhD, Beatrice Vergier MD, PhD Translational Research on Oncodermatology and Rare Skin Diseases, INSERM U1312, Bordeaux Institute of Oncology, Bordeaux University, Bordeaux, France Pathology Department, CHU Bordeaux, Bordeaux, FranceSearch for more papers by this authorItzia Peyrot MD, Itzia Peyrot MD Dermatology Department, CHU de Bordeaux, Bordeaux, FranceSearch for more papers by this authorMarie Beylot-Barry MD, PhD, Marie Beylot-Barry MD, PhD orcid.org/0000-0001-6150-1229 Dermatology Department, CHU de Bordeaux, Bordeaux, France Translational Research on Oncodermatology and Rare Skin Diseases, INSERM U1312, Bordeaux Institute of Oncology, Bordeaux University, Bordeaux, FranceSearch for more papers by this authorOcéane Ducharme MD, Corresponding Author Océane Ducharme MD [email protected] Dermatology Department, CHU de Bordeaux, Bordeaux, France Translational Research on Oncodermatology and Rare Skin Diseases, INSERM U1312, Bordeaux Institute of Oncology, Bordeaux University, Bordeaux, FranceSearch for more papers by this author First published: 13 October 2023 https://doi.org/10.1111/ijd.16879 Conflict of interest: None. Funding source: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Nelson CA, Zhong CS, Hashemi DA, Ashchyan HJ, Brown-Joel Z, Noe MH, et al. A multicenter cross-sectional study and systematic review of necrobiotic xanthogranuloma with proposed diagnostic criteria. JAMA Dermatol. 2020; 156: 270–279. 2Legrand A, Jullie ML, Ly S, Beylot-Barry M, Viallard JF, Calonje J, et al. Extrafacial necrobiotic xanthogranuloma and monoclonal gammopathy: two cases. Int J Dermatol. 2019; 58: e112–e114. 3Higgins LS, Go RS, Dingli D, Kumar SK, Rajkumar SV, Dispenzieri A, et al. Clinical features and treatment outcomes of patients with necrobiotic xanthogranuloma associated with monoclonal gammopathies. Clin Lymphoma Myeloma Leuk. 2016; 16: 447–452. 4Gergen N, Biebl K, Berg BC, Suwattee P. Slowly growing yellow nodules: challenge. Necrobiotic xanthogranuloma. Am J Dermatopathol 2011; 33:92–3, 103–4. 5Miguel D, Lukacs J, Illing T, Elsner P. Treatment of necrobiotic xanthogranuloma – a systematic review. J Eur Acad Dermatol Venereol. 2017; 31: 221–235. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation